Repeat: "Our results demonstrate that weekly, sel
Post# of 148292
(Total Views: 636)
Posted On: 04/01/2022 10:21:14 AM
Repeat: "Our results demonstrate that weekly, self-administered Leronlimab was safe, well-tolerated, and efficacious for long-term virologic suppression and should be included in the arsenal of safe, easily administered, longer-acting antiretroviral treatments for people living with HIV-1."
https://journals.plos.org/plospathogens/artic...V3uGGtXUm8
https://journals.plos.org/plospathogens/artic...V3uGGtXUm8
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼